The report is brought to you by WGR, a leading market research company. The report concludes different market segmentations and overviews and well researched forecast report.
Pharmacovigilance (PhV or PV) is a pharmacological science, also known as reliability in drugs, related to the collection, detection, evaluation and avoidance of negative drug-related impacts. This is a database, in other words. This is the ICSR database and the software used in the PV world to enter these cases. A recording system is a cost centre. There was a mistake. Software for pharmaceutical surveillance, from record system to intelligence scheme.
During the period 2014-19, the worldwide market for pharmacovigilance (PV) software will expand by 6.5% at a CAGR of 154.1 million USD by 2019. The growing worldwide pharmacovigilance (PV) software market is driven by factors such as rising drug negative reaction incidence rates (ADRs) and increased pharmacovigilance software adoption by outsourcing businesses. In addition, public regulators (such as the United States( EMEA and FDA) have stepped up security legislation for the pre-and post-marketing of pharmaceutical and biotech firms which has increased pressures on them to produce secure medicines and assess the outcomes of their post-sales operations.
The biggest share of the drug safety software market, followed by Europe, is anticipated to take place in North America in 2014. However, as a result of the increasing study outsourcing of the pharmaceutical giants and the increasing government and private investment in pharma-based R&D in these developing nations, the Asian and Latin American countries constitute high growth markets.
Based on the functionality of the worldwide pharmaceutical industry, the pharmacovigilance (PV) software reporting software, the drug safety auditing software, problem tracking software and completely integrating software are categorized into four main sections.
The worldwide market for software for drug security is broken down into two sections based on delivery mode: on-site delivery mode and on-demand / cloud delivery mode. This market is split into pharmaceutical and biotech businesses and contract research organisations, BPOs, and other suppliers of pharmaceutical services on the grounds of end users. This market also covers pharmaceutical and biotech businesses.
The market is divided into four areas and nations based on the areas, namely North America (U.S. and Canada), Europe (Germany, United Kingdom, France and Rest of Europe), Asia-Pacific (Japan, India, China and the Rest of the Asia-Pacific) and the Rest of the World (Africa, Latin America and the Middle East). The biggest share of the drug safety software industry is anticipated to be accounted for in North America in 2014 followed by Europe. Asian and Latin American countries, however, constitute high-growth economies because of an increase in pharmaceutical giant outsourcing studies and increasing government and private R&D investment in these developing economies.
Sellers are outsourced to developing economies such as India, China and the Philippines to cut operating cost and create revenue. pharmacovigilance operations and drug safety activities are outsourced. This trend should have a beneficial effect on the general development of the industry.
Table of Contents
Pharmacovigilance (PV) software Overview
Global Pharmacovigilance (PV) software Competition by Manufacturers, Type and Application
United States Pharmacovigilance (PV) software (Volume, Value and Sales Price)
China Pharmacovigilance (PV) software (Volume, Value and Sales Price)
Europe Pharmacovigilance (PV) software (Volume, Value and Sales Price)
Japan Pharmacovigilance (PV) software (Volume, Value and Sales Price)
Southeast Asia Pharmacovigilance (PV) software (Volume, Value and Sales Price)
India Pharmacovigilance (PV) software (Volume, Value and Sales Price)
Global Pharmacovigilance (PV) software Manufacturers Analysis
Pharmacovigilance (PV) software Maufacturing Cost Analysis
Industrial Chain, Sourcing Strategy and Downstream Buyers
Marketing Strategy Analysis, Distributors/Traders Market Effect Factors Analysis
Global Pharmacovigilance (PV) software Market Forecast (2016-2021)
Research Findings and Conclusion